Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS · Delayed Price · Currency is USD
11.13
+0.15 (1.37%)
Dec 26, 2025, 2:56 PM EST
Cipher Pharmaceuticals Revenue
Cipher Pharmaceuticals had revenue of $12.83M in the quarter ending September 30, 2025, with 23.75% growth. This brings the company's revenue in the last twelve months to $50.06M, up 89.17% year-over-year. In the year 2024, Cipher Pharmaceuticals had annual revenue of $33.36M with 57.66% growth.
Revenue (ttm)
50.06M
Revenue Growth
+89.17%
P/S Ratio
5.59
Revenue / Employee
10.01M
Employees
5
Market Cap
279.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.36M | 12.20M | 57.66% |
| Dec 31, 2023 | 21.16M | 487.00K | 2.36% |
| Dec 31, 2022 | 20.68M | -1.27M | -5.78% |
| Dec 31, 2021 | 21.94M | 336.00K | 1.56% |
| Dec 31, 2020 | 21.61M | -844.00K | -3.76% |
| Dec 31, 2019 | 22.45M | -298.00K | -1.31% |
| Dec 31, 2018 | 22.75M | -17.39M | -43.33% |
| Dec 31, 2017 | 40.14M | 10.49M | 35.38% |
| Dec 31, 2016 | 29.65M | -4.76M | -13.83% |
| Dec 31, 2015 | 34.41M | 5.19M | 17.74% |
| Dec 31, 2014 | 29.22M | 3.83M | 15.08% |
| Dec 31, 2013 | 25.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Cipher Pharmaceuticals News
- 4 weeks ago - Cipher Pharmaceuticals Has Potential - Seeking Alpha
- 6 weeks ago - Cipher Pharmaceuticals Inc (CPHRF) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 7 weeks ago - Q3 2025 Cipher Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
- 7 weeks ago - Cipher Pharmaceuticals Inc. (CPH:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - CIPHER PHARMACEUTICALS INC Profit Climbs In Q3, Beats Estimates - Nasdaq
- 2 months ago - Halvio Capital Q3 2025 Position Updates - Seeking Alpha
- 5 months ago - Cipher Pharmaceuticals Inc. (CPHRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue - Benzinga